Results 21 to 30 of about 4,616 (237)

Current Opinion on MRONJ

Journal of Surgery: Open Access, 2016
Lee JK
openalex   +2 more sources

Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)

International Journal of Oral Science, 2022
Medication-related osteonecrosis of the jaw (MRONJ) is primarily associated with administering antiresorptive or antiangiogenic drugs. Despite significant research on MRONJ, its pathogenesis and effective treatments are still not fully understood. Animal
Ran Yan, Ruixue Jiang, Longwei Hu, Yuwei Deng, Jin Wen, Xinquan Jiang   +5 more
doaj   +1 more source

Awareness, perceptions and attitudes toward medication-related osteonecrosis of the jaw among physicians who treat osteoporosis

Saudi Pharmaceutical Journal, 2023
Osteoporosis is the most common indication for antiresorptive drugs (ARDs). Medication-related osteonecrosis of the jaw (MRONJ) is a severe complication of ARDs.
Suad Aljohani
doaj   +1 more source

Guided Bone Regeneration (GBR) for Reconstructing Alveolar Bone Defects Following Resective Treatment of Medication-Related Osteonecrosis of the Jaws (MRONJ) Lesions: A Case Series. [PDF]

Clin Case Rep
This composite figure illustrates some of the clinical and radiographic features of medication‐related osteonecrosis of the jaw (MRONJ), including panoramic, intraoral, axial CBCT, and extraoral images highlighting intra‐oral to bone probing, radiographic lysis, sequestration and periosteal reaction, and facial swelling.
Masri D, Ghanaiem O, Raiser V, Adut S, Chaushu G.   +4 more
europepmc   +2 more sources

Medication-related osteonecrosis of the jaw: A review about etiology, risk factors, pathophysiology, and treatment

Journal of Indian Academy of Oral Medicine and Radiology, 2020
Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse effect of antiresorptive and antiangiogenic medication. MRONJ is considered when a patient has exposed bone in the jaw for more than 8 weeks and has a history of antiresorptive and ...
Sheetal Singar, Ajay Pratap Singh Parihar, Prashanthi Reddy, Abhishek Maurya, Vishal Bamaniya   +4 more
doaj   +1 more source

Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study

Journal of Dental Sciences, 2021
Background/purpose: Because the anatomy and the nature of the bone tissue between the mandible and maxilla are largely different, more site-specific studies are required to improve the healing rate on medication-related osteonecrosis of the jaw (MRONJ ...
Kohei Okuyama, Saki Hayashida, Satoshi Rokutanda, Akiko Kawakita, Sakiko Soutome, Shunsuke Sawada, Souichi Yanamoto, Yuka Kojima, Masahiro Umeda   +8 more
doaj   +1 more source

Medication-related osteonecrosis of the jaw treatment modalities: A review

Journal of Craniomaxillofacial Research, 2020
Introduction: Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction of antiresorptive and antiangiogenic agents. Management of MRONJ has remained a controversial topic within the oral and maxillofacial surgery community ...
Amir Ali Asadi
doaj   +1 more source

Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients

Scientific Reports, 2021
Tooth extraction has been avoided since it has been considered a major risk factor for medication-related osteonecrosis of the jaw (MRONJ). However, MRONJ may also develop from tooth that is an infection source.
Sakiko Soutome, Mitsunobu Otsuru, Saki Hayashida, Maho Murata, Souichi Yanamoto, Shunsuke Sawada, Yuka Kojima, Madoka Funahara, Hiroshi Iwai, Masahiro Umeda, Toshiyuki Saito   +10 more
doaj   +1 more source

Role of preoperative SPECT/CT standardized uptake values in medication-related osteonecrosis of the jaw: a preliminary study of SPECT/CT in relation to cone-beam CT and histopathological findings of the resected bone of mandibulectomy

The Egyptian Journal of Radiology and Nuclear Medicine, 2023
Background SPECT/CT has been applied for preoperative planning of MRONJ. Furthermore, the SUV using bone SPECT/CT has enabled quantitative analysis of jaw lesions.
Eizaburo Kobayashi, Yasuhito Tezuka, Junya Ono, Yasuo Okada, Ichiro Ogura   +4 more
doaj   +1 more source

Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review

International Journal of Implant Dentistry, 2021
Background Medication-related osteonecrosis of the jaw (MRONJ), which was first reported as bisphosphonate-related osteonecrosis of the jaw (BRONJ) in bisphosphonate users, is a rare but severe soft and hard tissue disease induced by several types of ...
Mampei Kawahara, Shinichiro Kuroshima, Takashi Sawase   +2 more
doaj   +1 more source